Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national
- PMID: 36306061
- PMCID: PMC9614750
- DOI: 10.1007/s11096-022-01466-9
Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national
Abstract
Background: Treatment for people with kidney disease is often associated with complicated combinations of medicines. Logistical challenges with traditiona paper-based prescribing means that these patients are particularly susceptible to medication-relation errors and harm.
Aim: To improve the quality of care that people with kidney disease receive across Wales through a Value-Based digital transformation programme.
Setting: Renal units within the National Welsh Renal Clinical Network (WRCN).
Development: A novel Electronic Prescribing & Medicines Administration (EPMA) system, integrated into a patient care record and linked to a patient portal was developed in South West Wales (SWW) region of the WRCN, enabled by the Welsh Government (WG) Efficiency Through Technology Fund. National upscale was enabled through the WG Transformation Fund.
Implementation: EPMA was designed and rolled out initially in SWW region of the WRCN (2018). A dedicated delivery team used the blueprint to finalise and implement a strategy for successful national roll-out eventually across all Wales (completed 2021).
Evaluation: A multi-factorial approach was employed, as both the technology itself and the healthcare system within which it would be introduced, were complex. Continuous cycles of action research involving informal and formal qualitative interviews with service-users ensured that EPMA was accessible and optimally engaging to all target stakeholders (patients and staff). Results confirmed that EPMA was successful in improving the quality of care that people with kidney disease receive across Wales, contributed to Value-Based outcomes, and put people who deliver and access care at the heart of transformation.
Conclusion: Key findings of this study align directly with the national design principles to drive change and transformation, put forward by the WG in their plan for Health and Social Care: prevention and early intervention; safety; independence; voice; seamless care.
Keywords: Electronic prescribing patient care; Kidney disease; Patient portal; Quality of care.
© 2022. The Author(s).
Conflict of interest statement
None.
Figures


Similar articles
-
Gwên am Byth: a programme introduced to improve the oral health of older people living in care homes in Wales - from anecdote, through policy into action.Br Dent J. 2020 Dec;229(12):793-799. doi: 10.1038/s41415-020-2400-2. Epub 2020 Dec 18. Br Dent J. 2020. PMID: 33339930 Free PMC article.
-
Critical Care Network in the State of Qatar.Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019. Qatar Med J. 2019. PMID: 31763205 Free PMC article.
-
Identifying integrated health services and social care research priorities in kidney disease in Wales: research prioritisation exercise.BMJ Open. 2020 Sep 1;10(9):e036872. doi: 10.1136/bmjopen-2020-036872. BMJ Open. 2020. PMID: 32873670 Free PMC article.
-
The Welsh Blood Service - 70 years of continuous change.Transfus Med. 2017 Jun;27(3):159-166. doi: 10.1111/tme.12401. Epub 2017 Mar 8. Transfus Med. 2017. PMID: 28271567 Review.
-
Delivering value-based healthcare for people with diabetes in a national publicly funded health service: Lessons from Ireland and Wales.J Diabetes Investig. 2023 Aug;14(8):925-929. doi: 10.1111/jdi.14023. Epub 2023 May 18. J Diabetes Investig. 2023. PMID: 37203299 Free PMC article. Review.
Cited by
-
European Society of Clinical Pharmacy: 'Implementing and scaling sustainable clinical pharmacy'.Int J Clin Pharm. 2024 Apr;46(2):355-356. doi: 10.1007/s11096-024-01718-w. Int J Clin Pharm. 2024. PMID: 38478210 No abstract available.
-
The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability.Int J Clin Pharm. 2024 Oct;46(5):1001-1009. doi: 10.1007/s11096-024-01775-1. Epub 2024 Jul 23. Int J Clin Pharm. 2024. PMID: 39042349 Free PMC article.
-
European Society of Clinical Pharmacy: 'the prescribing pharmacist: a prescription for better patient care'.Int J Clin Pharm. 2024 Dec;46(6):1245-1246. doi: 10.1007/s11096-024-01827-6. Int J Clin Pharm. 2024. PMID: 39535686 No abstract available.
-
European Society of Clinical Pharmacy: 'From interprofessional education to interprofessional practice'.Int J Clin Pharm. 2025 Jun;47(3):593-594. doi: 10.1007/s11096-025-01929-9. Int J Clin Pharm. 2025. PMID: 40327315 No abstract available.
-
Thank you from the Editor-in-Chief.Int J Clin Pharm. 2024 Feb;46(1):1-3. doi: 10.1007/s11096-023-01699-2. Int J Clin Pharm. 2024. PMID: 38240962 No abstract available.
References
-
- Welsh Government. A Healthier Wales: our Plan for Health and Social care. 2018. https://gov.wales/sites/default/files/publications/2019-10/a-healthier-w.... Accessed 07 Jun 2022
-
- Welsh Renal Clinical Network. Renal Services in Wales 2016–2020 Delivery Plan. 2016. http://www.wales.nhs.uk/sites3/Documents/773/Renal%20Disease%20Quality%2.... Accessed 07 Jun 2022
-
- NHS. Treatment. In: Chronic kidney disease. 2019. https://www.nhs.uk/conditions/kidney-disease/treatment/. Accessed 07 Jun 2022
-
- Chief Medical Officer for Wales’s special edition annual report 2019 to 2020: protecting our health. 2021. https://gov.wales/chief-medical-officer-waless-special-edition-annual-re.... Accessed 08 Jun 2022
MeSH terms
LinkOut - more resources
Full Text Sources
Medical